170 related articles for article (PubMed ID: 35234192)
1. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
2. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
5. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A
Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583
[TBL] [Abstract][Full Text] [Related]
6. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
7. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
Magro CM; Momtahen S; Kiuru M
Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
11. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
[TBL] [Abstract][Full Text] [Related]
12. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
13. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
14. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
15. A case of primary cutaneous anaplastic large cell lymphoma on eyelid.
Gong Y; Chen J; Shi Y
Indian J Dermatol Venereol Leprol; 2022; 88(3):444. PubMed ID: 35389030
[TBL] [Abstract][Full Text] [Related]
16. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
17. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
19. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
Parajuli S; Gurung D; Paudel U; Pokhrel DB; Kempf W
Int J Dermatol; 2014 Dec; 53(12):1498-500. PubMed ID: 24738699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
